Infectious Prospective Collection for Biological Analysis

Launched by CERBAXPERT · Dec 5, 2023

Keywords

ClinConnect Summary

This clinical trial, called "Infectious Prospective Collection for Biological Analysis," is focused on improving how medical laboratories test for infectious diseases. Researchers want to collect biological samples (like blood or other fluids) from patients to better understand how automated testing systems work and to compare the results with information provided by manufacturers of these testing tools. This study aims to enhance the accuracy and efficiency of tests, which could lead to better care for patients with infectious diseases.

Anyone between the ages of 6 and 74, including hospitalized patients, pregnant women, and those on dialysis, may be eligible to participate. Participants can expect to provide samples that will be analyzed to gather important data about these testing systems. It's important to note that individuals who have taken part in a similar study in the last 15 days, or those receiving specific experimental treatments, may not qualify. Overall, this trial is an opportunity to contribute to advancements in medical testing that could benefit many patients in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All-comers clinical subjects (ambulatory)
• • Hospitalized patients
• • Pregnant women (all comers)
• • Subjects on dialysis
• • Known subjects positive for targeted pathogens
• Exclusion Criteria:
• • Subject having already participated in this protocol within 15 days previous ones.
• • Subject having received medication or treatment experimental or investigational during the last four weeks before collection
• • Person subject to a judicial safeguard measure
• • Person not affiliated to the Social Security system and not not having social security coverage
• • Person not meeting the inclusion criteria